March 31, 2026 Rare/Orphan and Pediatric Disease Programs: Quarterly Newsletter March 2026 Welcome to the Rare/Orphan and Pediatric Disease Programs quarterly newsletter. In between major announcements...
March 31, 2026 C-Path Newsletter Q1 2026: Momentum in Motion As we close the first quarter of the year, we are energized by the opportunities ahead to further strengthen collaboration...
February 6, 2026 Use of AI within COA linguistic validation and eCOA migration processes: analysis and good practice recommendations While there has been much discussion around the use of Artificial Intelligence (AI) for multilingual translations in other...
December 12, 2025 Emerging Therapies in Autosomal Dominant Polycystic Kidney Disease Autosomal dominant polycystic kidney disease (ADPKD) is the most...
September 9, 2025 C-Path’s Global Impact Conference | Every Stage, Every Step: Transforming Lives Through Optimized Drug Development | Day 1 Recap Day 1 of Critical Path Institute's Global Impact Conference, #CGIC2025, opened with powerful conversations on accelerating...
September 4, 2025 From Data to Hope: C-Path’s Polycystic Kidney Disease Outcomes Consortium and the Power of Data Sharing Every year on September 4, families, patients, advocates, and researchers come together to recognize Polycystic Kidney Disease...
September 8, 2025 Shaping the Future of AATD: Patient Perspectives to Drive the Next Decade of Innovation in Alpha-1 Antitrypsin Deficiency On September 8, C-Path and the Alpha-1 Foundation are co-hosting a virtual workshop, Shaping the Future of AATD: Patient...
July 23, 2025 The Critical Path Institute Podcast: eCOA Conversations on Digital Health Technologies This newest podcast episode from Critical Path Institute’s® (C-Path) Electronic Clinical Outcome Assessment (eCOA)...
July 15, 2025 Preventing, Delaying Type 1 Diabetes Critical Path Institute, which formed the T1D Consortium in 2017, is working to accelerate the process to new therapies...
July 14, 2025 Principles of good practice for concept definition in the context of translation and linguistic validation of clinical outcome assessments (COAs) Translation teams conducting translation and cultural adaptation find it paramount to properly describe concepts of items...
